Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mavyret in Japanese Adults With Genotype 2 Chronic Hepatitis C (CERTAIN-2)
NCT02723084Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2016
- Primary completion
- Jan 2017
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 3 trial of glecaprevir in chronic hepatitis C virus infection (CHC), sponsored by AbbVie Inc.. Started Apr 2016; status: completed.
02
Drugs
glecaprevir
03
Conditions
chronic hepatitis C virus infection (CHC)
Beyond the preview
Go deeper on NCT02723084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02723084.